Primary Carnitine Deficiency Presents Atypically with Long QT Syndrome: A Case Report
- 6 September 2011
- book chapter
- Published by Springer Science and Business Media LLC
- Vol. 2, 87-90
- https://doi.org/10.1007/8904_2011_52
Abstract
Primary carnitine deficiency (PCD) is an autosomal recessive disorder of fatty acid oxidation caused by mutations in the SLC22A5 gene encoding for the carnitine transporter OCTN2. Carnitine uptake deficiency results in renal carnitine wasting and low plasma levels. PCD usually presents early in life either with acute metabolic crisis or as progressive cardiomyopathy that responds to carnitine supplementation. PCD inclusion in the newborn screening (NBS) programs has led to the identification of asymptomatic adult patients ascertained because of a positive NBS in their offspring. We extensively reviewed the literature and found that 15 of 42 adult published cases (35.7%) were symptomatic. Cardiac arrhythmias were present in five patients (12%). Here, we report the ascertainment and long-term follow-up of the first case of PCD presenting with long QT syndrome. The patient presented in her early twenties with a syncopal episode caused by ventricular tachycardia, and a prolonged QT interval. Arrhythmias were poorly controlled by pharmacologic therapy and a defibrillator was installed. Syncopal episodes escalated during her first pregnancy. A positive NBS in the patient’s child suggested a carnitine uptake deficiency, which was confirmed by reduced carnitine transporter activity and by molecular testing. After starting carnitine supplementation, no further syncopal episodes have occurred and the QT interval returned to normal. As precaution, a low-dose metoprolol therapy and the defibrillator are still in place. Although rare, PCD should be ruled out as a cause of cardiac arrhythmias since oral carnitine supplementation is readily available and efficient.Keywords
This publication has 12 references indexed in Scilit:
- Cardiac conduction improvement in two heterozygotes for primary carnitine deficiency on l‐carnitine supplementationClinical Genetics, 2010
- Diagnoses of newborns and mothers with carnitine uptake defects through newborn screeningMolecular Genetics and Metabolism, 2010
- Maternal systemic primary carnitine deficiency uncovered by newborn screening: Clinical, biochemical, and molecular aspectsGenetics in Medicine, 2010
- Cardiomyopathy and carnitine deficiencyMolecular Genetics and Metabolism, 2008
- Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe IslandsJournal of Inherited Metabolic Disease, 2007
- Carnitine transporter defect: Diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infantsJournal of Inherited Metabolic Disease, 2006
- Silent and symptomatic primary carnitine deficiency within the same family due toidentical mutations in the organic cation/carnitine transporter OCTN2Journal of Inherited Metabolic Disease, 2003
- Screening Newborns for Inborn Errors of Metabolism by Tandem Mass SpectrometryThe New England Journal of Medicine, 2003
- Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporterNature Genetics, 1999
- Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptakeAnnals of Neurology, 1991